TheEdgeResearch
Home / Stocks / PAVS

Paranovus Entertainment Technology Ltd. (PAVS)

NASDAQ Healthcare Medical - Pharmaceuticals
$6.90 ▼ -1.57%
Market Cap
$5.9M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-0.14
52-Wk Range
3.76-148800
CEO
Xiaoyue Zhang
Country
US
Currency
USD

Paranovus Entertainment Technology Ltd. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in New York, NY, US. The stock last traded at $6.90, down 1.57% on the session, giving a market capitalisation of $5.9M. On trailing twelve-month figures it carries a trailing P/E of -0.62, a net margin of -51.5%. Its beta of -0.14 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.62
Price / Sales
0.48
Price / Book
0.21
EV / EBITDA
-22.34
Gross margin
9.7%
Operating margin
-14.3%
Net margin
-51.5%
Return on equity
Debt / equity
0.24
Current ratio
1.15
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
28
IPO date
2019-10-25
Headquarters
New York, NY, US
About Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd. operates in the artificial intelligence (AI)-powered entertainment industry. The company focuses on providing AI-driven games and applications. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. Paranovus Entertainment Technology Ltd. was founded in 2004 and is based in New York, New York.

Comparable companies

Paranovus Entertainment Technology Ltd. is most often compared with the following Healthcare names:

BNKKBOFCOOTFARMIMGLSFNCRARYETWYHGYQ
More research on PAVS
PAVS technical analysis PAVS TheEdge Score Compare against peers
Open full interactive analysis & DCF →